Induction of hepatocyte growth factor expression by maleic acid in human fibroblasts through MAPK activation
Takahiro Motoki
Department of Immunochemistry, Division of Pharmaceutical Sciences, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Tsushima-naka, Okayama 700-8530, Japan
Search for more papers by this authorYoshihiro Sugiura
Department of Immunochemistry, Division of Pharmaceutical Sciences, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Tsushima-naka, Okayama 700-8530, Japan
Search for more papers by this authorYohsuke Matsumoto
Department of Immunochemistry, Division of Pharmaceutical Sciences, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Tsushima-naka, Okayama 700-8530, Japan
Search for more papers by this authorTomoe Tsuji
Department of Immunochemistry, Division of Pharmaceutical Sciences, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Tsushima-naka, Okayama 700-8530, Japan
Search for more papers by this authorSatoshi Kubota
Derpartment of Biochemistry and Molecular Dentistry, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Shikata-cho, Okayama 700-8525, Japan
Search for more papers by this authorMasaharu Takigawa
Derpartment of Biochemistry and Molecular Dentistry, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Shikata-cho, Okayama 700-8525, Japan
Search for more papers by this authorCorresponding Author
Eiichi Gohda
Department of Immunochemistry, Division of Pharmaceutical Sciences, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Tsushima-naka, Okayama 700-8530, Japan
Department of Immunochemistry, Division of Pharmaceutical Sciences, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Tsushima-naka, Okayama 00-8530, Japan.Search for more papers by this authorTakahiro Motoki
Department of Immunochemistry, Division of Pharmaceutical Sciences, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Tsushima-naka, Okayama 700-8530, Japan
Search for more papers by this authorYoshihiro Sugiura
Department of Immunochemistry, Division of Pharmaceutical Sciences, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Tsushima-naka, Okayama 700-8530, Japan
Search for more papers by this authorYohsuke Matsumoto
Department of Immunochemistry, Division of Pharmaceutical Sciences, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Tsushima-naka, Okayama 700-8530, Japan
Search for more papers by this authorTomoe Tsuji
Department of Immunochemistry, Division of Pharmaceutical Sciences, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Tsushima-naka, Okayama 700-8530, Japan
Search for more papers by this authorSatoshi Kubota
Derpartment of Biochemistry and Molecular Dentistry, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Shikata-cho, Okayama 700-8525, Japan
Search for more papers by this authorMasaharu Takigawa
Derpartment of Biochemistry and Molecular Dentistry, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Shikata-cho, Okayama 700-8525, Japan
Search for more papers by this authorCorresponding Author
Eiichi Gohda
Department of Immunochemistry, Division of Pharmaceutical Sciences, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Tsushima-naka, Okayama 700-8530, Japan
Department of Immunochemistry, Division of Pharmaceutical Sciences, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Tsushima-naka, Okayama 00-8530, Japan.Search for more papers by this authorAbstract
Carboxylic acids have various biological activities and play critical roles in cellular metabolic pathways such as the tricarboxylic acid (TCA) cycle. It has been shown that some carboxylic acids induce cell proliferation and production of cytokines or growth factors. However, there have been no reports on effects of carboxylic acids on hepatocyte growth factor (HGF) expression. In this study, we found that only maleic acid among various carboxylic acids examined markedly induced HGF production from human dermal fibroblasts. Maleic acid also induced HGF production from human lung fibroblasts and neuroblastoma cells. The stimulatory effect was accompanied by upregulation of HGF gene expression. Increase in phosphorylation of extracellular signal-regulated protein kinase (ERK) and c-Jun N-terminal kinase (JNK) but not in phosphorylation of p38 was observed from 6 h and up to 24 h after maleic acid addition. The ERK kinase inhibitor PD98059 and the JNK inhibitor SP600125 potently inhibited maleic acid-induced HGF production, while the p38 inhibitor SB203580 did not significantly inhibit the production. The protein synthesis inhibitor cycloheximide completely inhibited upregulation of HGF mRNA induced by maleic acid but superinduced HGF mRNA expression upregulated by 12-O-tetradecanoylphorbol 13-acetate (TPA). These results suggest that maleic acid indirectly induced HGF expression from human dermal fibroblasts through activation of ERK and JNK and that de novo protein synthesis is required for maleic acid-induced upregulation of HGF mRNA. J. Cell. Biochem. 104: 1465–1476, 2008. © 2008 Wiley-Liss, Inc.
REFERENCES
- Boot JH. 1996. Hepatotoxic effects of SH-reagents in human and rat hepatocyte cultures and in situ perfused rat livers. Cell Struct Funct 21: 221–229.
- Bottaro DP, Rubin JS, Faletto DL, Chan AM, Kmiecik TE, Vandes Woude GF, Aaronson SA. 1991. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science 251: 802–804.
- Broten J, Michalopoulos G, Petersen B, Cruise J. 1999. Adrenergic stimulation of hepatocyte growth factor expression. Biochim Biophys Res Commun 262: 76–79.
-
Burr AW,
Toole K,
Chapman C,
Hines JE,
Burt AD.
1998.
Anti-hepatocyte growth factor antibody inhibits hepatocyte proliferation during liver regeneration.
J Pathol
185:
298–302.
10.1002/(SICI)1096-9896(199807)185:3<298::AID-PATH88>3.0.CO;2-B CAS PubMed Web of Science® Google Scholar
- Cohen M, Marchand-Adam S, Lecon-Malas V, Marchal-Somme J, Boutten A, Durand G, Crestani B, Dehoux M. 2006. HGF synthesis in human lung fibroblasts is regulated by oncostatin M. Am J Physiol Lung Cell Mol Physiol 290: L1097–1103.
- Eiam-ong S, Spohn M, Kurtzman NA, Sabatini S. 1995. Insights into the biochemical mechanism of maleic acid-induced Fanconi syndrome. Kidney Int 48: 1542–1548.
- Gohda E, Tsubouchi H, Nakayama H, Hirono S, Sakiyama O, Takahashi K, Miyazaki H, Hashimoto S, Daikuhara Y. 1988. Purification and partial characterization of hepatocyte growth factor from plasma of a patient with fulminant hepatic failure. J Clin Invest 81: 414–419.
- Gohda E, Matsunaga T, Kataoka H, Takebe T, Yamamoto I. 1994. Induction of hepatocyte growth factor in human skin fibroblasts by epidermal growth factor, platelet-derived growth factor and fibroblast growth factor. Cytokine 6: 633–640.
- Harrison P, Bradley L, Bomford A. 2000. Mechanism of regulation of HGF/SF gene expression in fibroblasts by TGF-β1. Biochem Biophys Res Commun 271: 203–211.
- Huh CG, Factor VM, Sánchez A, Uchida K, Conner EA, Thorgeirsson SS. 2004. Hepatocyte growth factor/c-met signaling pathway is required for efficient liver regeneration and repair. Proc Natl Acad Sci USA 101: 4477–4482.
- Inaba M, Koyama H, Hino M, Okuno S, Terada M, Nishizawa Y, Nishino T, Morii H. 1993. Regulation of release of hepatocyte growth factor from human promyelocytic leukemia cells, HL-60, by 1,25-dihydroxyvitamin D3, 12-O-tetradecanoylphorbol 13-acetate, and dibutyryl cyclic adenosine monophosphate. Blood 82: 53–59.
- Jiang JG, Zarnegar R. 1997. A novel transcriptional regulatory region within the core promoter of the hepatocyte growth factor gene is responsible for its inducibility by cytokines via the C/EBP family of transcription factors. Mol Cell Biol 17: 5758–5770.
- Jiang JG, Chen Q, Bell A, Zarnegar R. 1997. Transcriptional regulation of the hepatocyte growth factor (HGF) gene by the Sp family of transcription factors. Oncogene 14: 3039–3049.
- Koivunen P, Hirsila M, Remes AM, Hassinen IE, Kivirikko KI, Myllyharju J. 2007. Inhibition of hypoxia-inducible factor (HIF) hydroxylases by citric acid cycle intermediates: Possible links between cell metabolism and stabilization of HIF. J Biol Chem 282: 4524–4532.
- Kruh J. 1982. Effects of sodium butyrate, a new pharmacological agent, on cells in culture. Mol Cell Biochem 42: 65–82.
- Larsen L, Størling J, Darville M, Eizirik DL, Bonny C, Billestrup N, Mandrup-Poulsen T. 2005. Extracellular signal-regulated kinase is essential for interleukin-1-induced and nuclear factor κB-mediated gene expression in insulin-producing INS-1E cells. Diabetologia 48: 2582–2590.
- Li Y, Sattler GL, Pitot HC. 1993. Oxaloacetate induces DNA synthesis and mitosis in primary cultured rat hepatocytes in the absence of EGF. Biochem Biophys Res Commun 193: 1339–1346.
- Liu Y, Michalopoulos GK, Zarnegar R. 1994. Structural and functional characterization of the mouse hepatocyte growth factor gene promoter. J Biol Chem 269: 4152–4160.
- Marcinkowska E, Garay E, Gocek E, Chrobak A, Wang X, Studzinski GP. 2006. Regulation of C/EBPβ isoforms by MAPK pathways in HL60 cells induced to differentiate by 1,25-dihydroxyvitamin D3. Exp Cell Res 312: 2054–2065.
- Matsumoto K, Tajima H, Okazaki H, Nakamura T. 1993. Heparin as an inducer of hepatocyte growth factor. J Biochem 114: 820–826.
- Matsunaga T, Gohda E, Takebe T, Wu YL, Iwao M, Kataoka H, Yamamoto I. 1994. Expression of hepatocyte growth factor is up-regulated through activation of a cAMP-mediated pathway. Exp Cell Res 210: 326–335.
- Michalopoulos GK, DeFrances MC. 1997. Liver regeneration. Science 276: 60–66.
- Michalopoulos G, Cianciulli HD, Novotny AR, Kligerman AD, Strom SC, Jirtle RL. 1982. Liver regeneration studies with rat hepatocytes in primary culture. Cancer Res 42: 4673–4682.
- Mitchell RL, Henning-Chubb C, Huberman E, Verma IM. 1986. c-fos expression is neither sufficient nor obligatory for differentiation of monomyelocytes to macrophages. Cell 45: 497–504.
- Miyazawa K, Tsubouchi H, Naka D, Takahashi K, Okigaki M, Arakaki N, Nakayama H, Hirono S, Sakiyama O, Takahashi K, Gohda E, Daikuhara Y, Kitamura N. 1989. Molecular cloning and sequence analysis of cDNA for human hepatocyte growth factor. Biochem Biophys Res Commun 163: 967–973.
- Miyazawa K, Kitamura A, Kitamura N. 1991. Structural organization and the transcription initiation site of the human hepatocyte growth factor gene. Biochemistry 30: 9170–9176.
- Motoki T, Takami Y, Yagi Y, Tai A, Yamamoto I, Gohda E. 2005. Inhibition of hepatocyte growth factor induction in human dermal fibroblasts by tryptanthrin. Biol Pharm Bull 28: 260–266.
- Murray B, Wilson DJ. 2001. A study of metabolites as intermediate effectors in angiogenesis. Angiogenesis 4: 71–77.
- Nakamura T, Nawa K, Ichihara A, Kaise N, Nishino T. 1987. Purification and subunit structure of hepatocyte growth factor from rat platelets. FEBS Lett 224: 311–316.
- Nakamura T, Nishizawa T, Hagiya M, Seki T, Shimonishi M, Sugimura A, Tashiro K, Shimizu S. 1989. Molecular cloning and expression of human hepatocyte growth factor. Nature 342: 440–443.
- Naldini L, Vigna E, Narsimhan RP, Gaudino G, Zarnegar R, Michalopoulos GK, Comoglio PM. 1991. Hepatocyte growth factor (HGF) stimulates the tyrosine kinase activity of the receptor encoded by the proto-oncogene c-MET. Oncogene 6: 501–504.
- Rosen EM, Goldberg ID, Kacinski BM, Buckholz T, Vinter DW. 1989. Smooth muscle releases an epithelial cell scatter factor which binds to heparin. In Vitro Cell Dev Biol 25: 163–173.
- Rosen EM, Joseph A, Jin L, Rockwell S, Elias JA, Knesel J, Wines J, McClellan J, Kluger MJ, Goldberg ID, Zitnik R. 1994. Regulation of scatter factor production via a soluble inducing factor. J Cell Biol 127: 225–234.
- Roth KS, Goldmann DR, Segal S. 1978. Developmental aspects of maleic acid-induced inhibition of sugar and amino acid transport in the rat renal tubule. Pediatr Res 12: 1121–1126.
- Schmidt C, Bladt F, Goedecke S, Brinkmann V, Zschiesche W, Sharpe M, Gherardi E, Birchmeier C. 1995. Scatter factor/hepatocyte growth factor is essential for liver development. Nature 373: 699–702.
- Stoker M, Gherardi E, Perryman M, Gray J. 1987. Scatter factor is a fibroblast-derived modulator of epithelial cell mobility. Nature 327: 239–242.
- Strain AJ, McGowan JA, Bucher NL. 1982. Stimulation of DNA synthesis in primary cultures of adult rat hepatocytes by rat platelet-associated substance(s). In Vitro 18: 108–116.
- Takami Y, Motoki T, Yamamoto I, Gohda E. 2005a. Synergistic induction of hepatocyte growth factor in human skin fibroblasts by the inflammatory cytokines interleukin-1 and interferon-γ. Biochem Biophys Res Commun 327: 212–217.
- Takami Y, Yamamoto I, Tsubouchi H, Gohda E. 2005b. Modulation of hepatocyte growth factor induction in human skin fibroblasts by retinoic acid. Biochim Biophys Acta 1743: 49–56.
- Tamura M, Arakaki N, Tsubouchi H, Takada H, Daikuhara Y. 1993. Enhancement of human hepatocyte growth factor production by interleukin-1α and -1β and tumor necrosis factor-α by fibroblasts in culture. J Biol Chem 268: 8140–8145.
- Tomida M, Saito T. 2004. The human hepatocyte growth factor (HGF) gene is transcriptionally activated by leukemia inhibitory factor through the Stat binding element. Oncogene 23: 679–686.
- Tsubouchi H, Niitani Y, Hirono S, Nakayama H, Gohda E, Arakaki N, Sakiyama O, Takahashi K, Kimoto M, Kawakami S, Setoguchi M, Tachikawa T, Shin S, Arima T, Daikuhara Y. 1991. Levels of the human hepatocyte growth factor in serum of patients with various liver diseases determined by an enzyme-linked immunosorbent assay. Hepatology 13: 1–5.
- Uehara Y, Minowa O, Mori C, Shiota K, Kuno J, Noda T, Kitamura N. 1995. Placental defect and embryonic lethality in mice lacking hepatocyte growth factor/scatter factor. Nature 373: 702–705.
- Verani RR, Brewer ED, Ince A, Gibson J, Bulger RE. 1982. Proximal tubular necrosis associated with maleic acid administration to the rat. Lab Invest 46: 79–88.
- Wierenga AT, Vogelzang I, Eggen BJ, Vellenga E. 2003. Erythropoietin-induced serine 727 phosphorylation of STAT3 in erythroid cells is mediated by a MEK-, ERK-, and MSK1-dependent pathway. Exp Hematol 31: 398–405.
- Wojcik EJ, Sharifpoor S, Miller NA, Wright TG, Watering R, Tremblay EA, Swan K, Mueller CR, Elliott BE. 2006. A novel activating function of c-Src and Stat3 on HGF transcription in mammary carcinoma cells. Oncogene 25: 2773–2784.
- Yagi Y, Sotani T, Nagao T, Horio T, Yamamoto I, Gohda E. 2003. Induction by staurosporine of hepatocyte growth factor production in human skin fibroblasts independent of protein kinase inhibition. Biochem Pharmacol 66: 1797–1808.
- Yasuda H, Imai E, Shiota A, Fujise N, Morinaga T, Higashio K. 1996. Antifibrogenic effect of a deletion variant of hepatocyte growth factor on liver fibrosis in rats. Hepatology 24: 636–642.
- Zarnegar R, Michalopoulos G. 1989. Purification and biological characterization of human hepatopoietin A, a polypeptide growth factor for hepatocytes. Cancer Res 49: 3314–3320.